{"nct_id":"NCT01178073","title":"A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2010-10-01","start_date_type":null,"primary_completion_date":"2014-07-31","primary_completion_date_type":"ACTUAL","completion_date":"2014-07-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}